A Class in Session: Understanding Current and Future Therapeutic Advances Across B-Cell Lymphomas

Download All
In this comprehensive online program, experts discuss how to select optimal therapies for patients with B-cell lymphomas. Get up to date with expert commentaries, an on-demand webcast and slides from a dynamic CCO symposium at ASH 2021, downloadable resources on 10 key agent classes, and an audio podcast.
Brad S. Kahl, MD
John P. Leonard, MD
Julie M. Vose, MD, MBA

Downloadable Slidesets

Download this slideset from a live satellite symposium at ASH 2021 on current and emerging treatment options for patients with follicular lymphoma.

John P. Leonard, MD Released: December 15, 2021

Download this slideset from a live satellite symposium at ASH 2021 on current and emerging treatment options for patients with marginal zone lymphoma and mantle cell lymphoma.

Brad S. Kahl, MD Released: December 16, 2021

Download this slideset from a live satellite symposium at ASH 2021 on current and emerging treatment options for patients with marginal zone lymphoma and mantle cell lymphoma.

Julie M. Vose, MD, MBA Released: December 16, 2021

Download this slideset from a live satellite symposium at ASH 2021 on current and emerging treatment options for patients with EBV-associated post-transplant lymphoproliferative disorders.

Julie M. Vose, MD, MBA Released: December 16, 2021

Gain key clinical insights fast, with this short slideset from CCO on key considerations for optimal treatment of B-cell lymphomas.

Brad S. Kahl, MD John P. Leonard, MD Julie M. Vose, MD, MBA Released: January 4, 2022
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Atara Biotherapeutics, Inc.
Bayer HealthCare Pharmaceuticals Inc.
BeiGene, Ltd.
Epizyme
Genentech, a member of the Roche Group
Genmab US, Inc.
Incyte Corporation
Karyopharm Therapeutics
Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings